Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chronic rhinosinusitis: Endotypes, biomarkers, and treatment response

Similar presentations


Presentation on theme: "Chronic rhinosinusitis: Endotypes, biomarkers, and treatment response"— Presentation transcript:

1 Chronic rhinosinusitis: Endotypes, biomarkers, and treatment response
Jose Gurrola, MD, Larry Borish, MD  Journal of Allergy and Clinical Immunology  Volume 140, Issue 6, Pages (December 2017) DOI: /j.jaci Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Patterns of TH1/TH2/TH17 cytokine expression in samples from patients with CRSwNP: Benelux (A), Berlin (B), Adelaide (C), Beijing (D), Chengdu (E), and Tochigi (F). Reproduced with permission from Wang et al.7 Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Tissue eosinophil distribution in NP samples. Eosinophils were counted in ten ×400 high-power fields. These figures display the range of distribution of the eosinophils enumerated in nasal polyps as a function of average (A) and peak (B) expression. For the distribution of eosinophil numbers, “[“ indicates inclusion of that number and “)” indicates less than that number. Reproduced with permission from Steinke et al.18 Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions


Download ppt "Chronic rhinosinusitis: Endotypes, biomarkers, and treatment response"

Similar presentations


Ads by Google